Literature DB >> 15545087

Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin.

Masayuki Yokoyama1, Praneet Opanasopit, Teruo Okano, Kumi Kawano, Yoshie Maitani.   

Abstract

A water-insoluble anti-cancer agent, camptothecin (CPT) was incorporated to a polymeric micelle carrier system forming from poly(ethylene glycol)-poly(aspartate) block copolymers. Incorporation efficiency and stability were analyzed in correlation with chemical structures of the inner core-forming hydrophobic blocks as well as with incorporation methods. Among three incorporation methods (dialysis, emulsion and evaporation methods), an evaporation method brought about much higher CPT yields with less aggregation than the other two methods. By the evaporation method, CPT was incorporated to polymeric micelles in considerably high yields and with high stability using block copolymers possessing high contents of benzyl and methylnaphtyl ester groups as hydrophobic moieties. This indicates importance of molecular design of the hydrophobic block chain to obtain targeting using polymeric micelle carriers as well as importance of the drug incorporation method.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545087     DOI: 10.1080/10611860412331285251

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  11 in total

1.  Antitumor activity of peptide amphiphile nanofiber-encapsulated camptothecin.

Authors:  Stephen Soukasene; Daniel J Toft; Tyson J Moyer; Hsuming Lu; Hyung-Kun Lee; Stephany M Standley; Vincent L Cryns; Samuel I Stupp
Journal:  ACS Nano       Date:  2011-11-01       Impact factor: 15.881

2.  Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer.

Authors:  Jaehee Choi; Hyunjin Kim; Yongdoo Choi
Journal:  Quant Imaging Med Surg       Date:  2015-10

Review 3.  Drug targeting with nano-sized carrier systems.

Authors:  Masayuki Yokoyama
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

4.  Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.

Authors:  Takanori Kanazawa; Hiroyuki Taki; Ko Tanaka; Yuuki Takashima; Hiroaki Okada
Journal:  Pharm Res       Date:  2011-04-16       Impact factor: 4.200

5.  Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Authors:  Kishore Cholkar; Ashaben Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Recent Pat Nanomed       Date:  2012

6.  Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting.

Authors:  Praneet Opanasopit; Masayuki Yokoyama; Masato Watanabe; Kumi Kawano; Yoshie Maitani; Teruo Okano
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

7.  Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.

Authors:  Rupa R Sawant; Rishikesh M Sawant; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-04-29       Impact factor: 5.571

8.  Anti-tumor effect of all-trans retinoic acid loaded polymeric micelles in solid tumor bearing mice.

Authors:  Narin Chansri; Shigeru Kawakami; Masayuki Yokoyama; Tatsuhiro Yamamoto; Pensri Charoensit; Mitsuru Hashida
Journal:  Pharm Res       Date:  2007-07-31       Impact factor: 4.200

9.  Biodegradable amphiphilic block-graft copolymers based on methoxy poly(ethylene glycol)-b-(polycarbonates-g-polycarbonates) for controlled release of doxorubicin.

Authors:  Tao Jiang; Youmei Li; Yin Lv; Yinjia Cheng; Feng He; Renxi Zhuo
Journal:  J Mater Sci Mater Med       Date:  2013-09-24       Impact factor: 3.896

10.  Self-assembled chitosan-ceramide nanoparticle for enhanced oral delivery of paclitaxel.

Authors:  Gantumur Battogtokh; Young Tag Ko
Journal:  Pharm Res       Date:  2014-05-14       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.